Jamie N. Anastas - Concepedia

Author

Jamie N. Anastas

Howard Hughes Medical Institute ORCID

Also Known As

Anastas, Jamie, Anastas, Jamie N., J N Anastas, Jamie Anastas, Jamie N Anastas, Jamie N. Anastas

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

Howard Hughes Medical Institute University of Washington Harvard University Brigham and Women's Hospital Boston Children's Hospital

About

Jamie N. Anastas is an author at Howard Hughes Medical Institute specializing in medicine, radiation oncology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	404
2	Cell Biology	3	3	386
3	Health Sciences	1	1	18
4	Natural Sciences	1	1	180
5	Immunology	1	1	171

Jamie N. Anastas

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Mesenchymal Stromal Cell Exosomes Ameliorate Experimental Bronchopulmonary Dysplasia and Restore Lung Function through Macrophage Immunomodulation Gareth R. Willis, Angeles Fernandez‐Gonzalez, Jamie N. Anastas, American Journal of Respiratory and Critical Care Medicine	2017	612
Re-programing Chromatin with a Bifunctional LSD1/HDAC Inhibitor Induces Therapeutic Differentiation in DIPG Jamie N. Anastas, Barry M. Zee, Jay H. Kalin, Cancer Cell Histone ModificationsChromatinRe-programing ChromatinChromatin RemodelingNatural Sciences	2019	180
WNT5A enhances resistance of melanoma cells to targeted BRAF inhibitors Jamie N. Anastas, Rima M. Kulikauskas, Tigist Y. Tamir, Journal of Clinical Investigation Brafi TherapyMedicineReceptor Tyrosine KinaseMelanomaImmunology	2014	171
New Regulators of Wnt/β-Catenin Signaling Revealed by Integrative Molecular Screening Michael B. Major, Brian S. Roberts, Jason D. Berndt, Science Signaling	2008	156
A protein complex of SCRIB, NOS1AP and VANGL1 regulates cell polarity and migration, and is associated with breast cancer progression Jamie N. Anastas, Travis L. Biechele, Mélanie Robitaille, Oncogene	2011	127
Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling Jason D. Berndt, Atsushi Aoyagi, Pei‐Tzu Yang, The Journal of Cell Biology	2011	98
Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors Frank Y. Lin, Austin J. Stuckert, Candise Tat, Journal of Clinical Oncology	2024	53
WLS inhibits melanoma cell proliferation through the β‐catenin signalling pathway and induces spontaneous metastasis Pei‐Tzu Yang, Jamie N. Anastas, Rachel A. Toroni, EMBO Molecular Medicine Cancer ResearchMedicineInduces Spontaneous MetastasisMelanomaCancer Cell Biology	2012	35
RACK7 recognizes H3.3G34R mutation to suppress expression of MHC class II complex components and their delivery pathway in pediatric glioblastoma Fangfang Jiao, Ze Li, Chen He, Science Advances	2020	34
A road map for the treatment of pediatric diffuse midline glioma Carl Koschmann, Wajd N. Al‐Holou, Marta M. Alonso, Cancer Cell Neuro-oncologyPediatric Brain TumorsPediatric NeurosurgeryMedicineRoad Map	2023	18

Page 1